These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24287765)

  • 1. Learning from the 2012-2013 class of breakthrough therapies.
    Mullard A
    Nat Rev Drug Discov; 2013 Dec; 12(12):891-3. PubMed ID: 24287765
    [No Abstract]   [Full Text] [Related]  

  • 2. Breakthrough programme turns two.
    Mullard A
    Nat Rev Drug Discov; 2014 Dec; 13(12):873-5. PubMed ID: 25435204
    [No Abstract]   [Full Text] [Related]  

  • 3. Accelerated approval dust begins to settle.
    Mullard A
    Nat Rev Drug Discov; 2011 Oct; 10(11):797-8. PubMed ID: 22037027
    [No Abstract]   [Full Text] [Related]  

  • 4. Target small firms for antibiotic innovation.
    Hwang TJ; Carpenter D; Kesselheim AS
    Science; 2014 May; 344(6187):967-9. PubMed ID: 24876477
    [No Abstract]   [Full Text] [Related]  

  • 5. Effective global drug development strategy for obtaining regulatory approval in Japan in the context of ethnicity-related drug response factors.
    Ichimaru K; Toyoshima S; Uyama Y
    Clin Pharmacol Ther; 2010 Mar; 87(3):362-6. PubMed ID: 20107436
    [No Abstract]   [Full Text] [Related]  

  • 6. A need for speed: Signals in drug development.
    Nat Med; 2012 Dec; 18(12):1730-1. PubMed ID: 23223053
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of neglected tropical disease drug and vaccine development pipelines to predict issuance of FDA priority review vouchers over the next decade.
    Stefanakis R; Robertson AS; Ponder EL; Moree M
    PLoS Negl Trop Dis; 2012; 6(10):e1803. PubMed ID: 23145186
    [No Abstract]   [Full Text] [Related]  

  • 8. [New perspective for drug discovery and clinical development in kidney disease].
    Miyata T; Kikuchi K; Saito K
    Nihon Jinzo Gakkai Shi; 2012; 54(5):610-4. PubMed ID: 22991841
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug development research: diabetes favored over cardiovascular disease?
    Suckling K
    Curr Opin Investig Drugs; 2009 Mar; 10(3):217-9. PubMed ID: 19333877
    [No Abstract]   [Full Text] [Related]  

  • 10. Two decades of new drug development for central nervous system disorders.
    Kesselheim AS; Hwang TJ; Franklin JM
    Nat Rev Drug Discov; 2015 Dec; 14(12):815-6. PubMed ID: 26585536
    [No Abstract]   [Full Text] [Related]  

  • 11. The special treatment.
    Osborne R
    Nat Biotechnol; 2008 May; 26(5):487-9. PubMed ID: 18464770
    [No Abstract]   [Full Text] [Related]  

  • 12. Heat-shock protein-based vaccines for cancer and infectious disease.
    Binder RJ
    Expert Rev Vaccines; 2008 Apr; 7(3):383-93. PubMed ID: 18393608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward molecular imaging-driven drug development in oncology.
    de Vries EG; Oude Munnink TH; van Vugt MA; Nagengast WB
    Cancer Discov; 2011 Jun; 1(1):25-8. PubMed ID: 22586317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit the patient, manage the risk: a system goal.
    Califf RM
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):269-76. PubMed ID: 15133777
    [No Abstract]   [Full Text] [Related]  

  • 15. HDAC inhibitors overcome first hurdle.
    Garber K
    Nat Biotechnol; 2007 Jan; 25(1):17-9. PubMed ID: 17211382
    [No Abstract]   [Full Text] [Related]  

  • 16. Breakthrough drug category demands more communication.
    Carroll J
    Manag Care; 2013 Aug; 22(8):17-8. PubMed ID: 24024248
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug safety sciences and the bottleneck in drug development.
    Watkins PB
    Clin Pharmacol Ther; 2011 Jun; 89(6):788-90. PubMed ID: 21593756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug development in Japan from the viewpoints of global pharmaceutical companies].
    Seriu T
    Rinsho Ketsueki; 2009 Jul; 50(7):556-62. PubMed ID: 19638723
    [No Abstract]   [Full Text] [Related]  

  • 19. The COPD Pipeline XIII.
    Gross NJ
    COPD; 2011 Dec; 8(6):464-5. PubMed ID: 22149408
    [No Abstract]   [Full Text] [Related]  

  • 20. An accelerated pathway for targeted cancer therapies.
    McClellan M; Benner J; Schilsky R; Epstein D; Woosley R; Friend S; Sidransky D; Geoghegan C; Kessler D
    Nat Rev Drug Discov; 2011 Feb; 10(2):79-80. PubMed ID: 21283090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.